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Introduction. Complementary and alternative medicines (CAMs) are commonly used among lactating women, despite the poor
knowledge of these products and of their safety. Perception of pregnancy- and breastfeeding-related difficulties and consequent
use of CAMs may differ in bereaved women, by force of the distress related to previous loss, although no literature evidence is
available. This Herbal supplements in Breastfeeding InvesTigation (HaBIT) post hoc analysis explored the impact of previous
pregnancy loss on lactating behaviors and on use of CAMs during breastfeeding. Methods. A web-based survey was conducted
among lactating women with no previous alive child, resident in Tuscany (Italy). Data on lactating behavior and on CAMs use
were collected and evaluated among women with previous pregnancy loss as compared to control women. Results. Out of 476
women answering the questionnaire, 233 lactating women with one child were considered. Of them, 80 had history of pregnancy
loss. Cesarean birth was significantly more frequent among women with history of pregnancy loss as compared to controls (41%
versus 22%; p=0.004). Proportion, length of exclusive breastfeeding, and occurrence of breastfeeding-related complications were
comparable among the two cohorts. More than half of women used CAMs during breastfeeding. Use of CAMs was more frequent
among women with previous pregnancy loss (54% versus 68%; p=0.050), specifically considering herbal preparations (16% versus
30%; p=0.018). Major advisors for CAMs use were midwives. 18% and 23% of women without and with history of pregnancy loss
declared no clear perception on CAMs efficacy and safety. Conclusion. Overcoming the social taboo of pregnancy loss and training
healthcare professionals for an adequate management of the perinatal period are essential for an effective and safe care. Despite
the common use and advice on CAMs use during breastfeeding, it is important to acknowledge that limited evidence supports
their safety and efficacy during such critical period.
1. Introduction
Miscarriage and stillbirth are among the most impactful
events in women’s life. Miscarriage, defined as spontaneous
loss of pregnancy within 24 weeks from conception, occurs
in up to 15% of pregnancies [1]. Rate of stillbirth, i.e., spon-
taneous loss after 24 weeks of gestation, in high income
countries is estimated to be 3.5 per 1000 total births [2].
The psychological implications of these events include
depression, anxiety, grief, posttraumatic stress disorder [2, 3],
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and may impacts on the couple and family relationship, as
well as on subsequent pregnancies [4, 5]. It is estimated that
about 50%of couples that experience perinatal loss try to have
a new pregnancy within a year [6, 7]. An integrative review
of 15 articles points out that perinatal loss can overshadow
the enjoyment and cause psychological distress in subsequent
pregnancy [8], with evidence suggesting that anxiety, depres-
sion, and stress during pregnancy negatively impact on fetal
and child development [9]. In addition, previous stillbirth is
associated with increased risk of recurrent stillbirths, as well
as with various adverse pregnancy outcomes, some of which
are iatrogenic [10].
There is currently little evidence to guide healthcare
providers in managing pregnancies subsequent to stillbirth
[11, 12]. According to an Australian Internet-based survey,
women often wish increased fetal surveillance and early
delivery [13]. A web-based survey on 2716 parents, from 40
high- andmiddle-income countries, showed that pregnancies
subsequent to stillbirth effectively had extra antenatal visits
and ultrasound scan monitoring, but parents rarely had
extra psychological support. Even when provided, support
by healthcare providers was of poor quality, particularly
considering listening and involvement in decisions [10].
Reasons for these unmet needs partially rely on the insuffi-
cient practice and training of healthcare providers caring for
women experiencing a stillbirth: based on a nationwide cross-
sectional survey, Italian healthcare providers felt inadequate
and wanted professional training courses to better support
bereaved families [14]. Poor support by trained healthcare
personnel is not limited to the gestational period, but further
involves the postpartum: lack of proper sanitary support
in this phase is a major clinical issue, considering that
breastfeeding may be related to different complications that
may also require medications use. In a national web-based
survey conducted on 388 lactating women in the frame
of the Herbal supplements in Breastfeeding InvesTigation
(HaBIT), 204 women declared use of complementary and
alternative medicines (CAMs) during breastfeeding, mainly
for the treatment of engorgement and breast fissures [15].
CAMs use was particularly high for women at the first
child, and most of them informed their doctor of CAMs
use during lactation. In fact, these kinds of treatments,
being natural, are considered by women and some healthcare
providers as safer compared to conventional drugs [16, 17].
The perception of an inadequate healthcare support may
potentiate the tendency of women towards self-medication.
This issue is of particular medical relevance, considering
that CAMs’ active ingredients are chemicals that share
with traditional medications the potential to cause serious
adverse effects [18]. To our knowledge, there is no evidence
on attitudes towards the use of herbal medicines among
breastfeeding women with previous pregnancy loss. Thus,
the purpose of this post hoc analysis of the HaBIT study
was to explore the impact of previous pregnancy loss on the
lactating behaviors and on use of herbal medicines during
breastfeeding.
2. Materials and Methods
2.1. Study Design. This is an observational study based on a
web survey conducted over a six-year period (from February
1, 2012, to October 31, 2017). The methodology for data
collection and the administered questionnaire have been
extensively described elsewhere [15].
2.2. Data Collection. Briefly, a semistructured web-based
questionnaire was administered using SurveyMonkey© web
platform to a sample of lactating women, resident in Italy
and attending the services of CiaoLapo Onlus, Charity for
Healthy Pregnancy and Perinatal Loss Support. The 36-
item questionnaire was designed and planned according
to specific methodological literature [19–21] and was vali-
dated by an ad hoc panel of experts (pharmacologists, epi-
demiologists, toxicologists, pharmacists, and gynecologists)
of the Tuscan Regional Centre of Pharmacovigilance and
Phytovigilance and a clinician of the Center for Integrative
Medicine.
The questionnaire provided information on (i) sociode-
mographic characteristics, including educational level, num-
ber of children, number of pregnancies, and type of delivery;
(ii) lactating behavior and use of CAMs during current
breastfeeding or during pregnancy; (iii) attitude towards
CAMs in terms of perceived efficacy and safety; and (iv)
benefits and adverse events experienced during CAMs
use.
As forCAMs use during breastfeeding, reported products
were classified in the following categories by a trained special-
ist by means of the European Pharmacopeia [22]: acupunc-
ture, chiropractic/osteopathy/manual medicine, dietary sup-
plements, domestic and traditional preparations, herbal
preparations, homeopathy, natural galenical preparations,
and phytotherapy.
2.3. Study Population. Based on provided answers, we
included in the study only women that declared themselves
to be lactating at the time of questionnaire or to have been
lactating in the previous six months. We further excluded
all women that declared themselves to have more than one
child, thus limiting the study to the first breastfeeding. Based
on the declared history of pregnancies, we stratified women
into two classes: (i) women who reported no history of
pregnancy loss (defined as “control women”) and (ii) women
who declared one or more previous events of pregnancy
loss.
2.4. Data Analysis. Sociodemographic characteristics, lactat-
ing behavior, use and attitude towards CAMs, and phytovigi-
lance information were compared among women with versus
without history of pregnancy loss.
Categorical variables were expressed as percentage value
and compared using the Fisher exact test, while continuous
variables were reported as median value and interquartile
range (IQR) and compared using the Mann-Whitney test.
A p-value <0.05 was considered statistically significant. All
analyses were performed using the software STATA version
14.
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Median age (IQR), years 34 (31-37) 34 (30-37) 34 (32-37) 0.396
Educational level
Middle school certificate 13 (5.58) 8 (5.23) 5 (6.25) 0.871
High school certificate 79 (33.91) 51 (33.33) 28 (35.00)
University degree 141 (60.52) 94 (61.44) 47 (58.75)
Median age of newborn (IQR),
months 12 (5-19) 11 (5-17) 13.50 (6 -21) 0.073
Type of birth
Vaginal without anesthesia 112 (48.07) 81 (52.94) 31 (38.75) 0.004∗
Vaginal with anesthesia 41 (17.60) 26 (16.99) 15 (18.75)
Vacuum-assisted vaginal delivery 13 (5.58) 12 (7.84) 1 (1.25)
Caesarian 67 (28.76) 34 (22.22) 33 (41.25)
∗from Fisher exact test
3. Results
A total of 476 women responded to the web-based interview.
After exclusion of nonlactating women (n=32), of question-
naires with no items completed (n=16), and of women with
more than one child (n=195), 233 lactating women with one
child were considered (see Table 1). Of them, 80 presented a
story of pregnancy loss. Overall, the median age was 34 years
(IQR 31-37), andmost women had a university degree (n=141;
60.52%), with no significant difference among women with
versus without history of pregnancy loss.
The median age of newborns was 12 months (5-19). With
regard to the type of delivery, 112 and 41 women (48.07
and 17.60%) had vaginal delivery without and with anesthe-
sia, respectively, whereas 67 women (28.67%) had a C-sec-
tion. Cesarean birth was significantly more frequent among
women with history of pregnancy loss (n=33; 41.25%) as
compared to control women (n=34; 22.22%) (p=0.004).
Information on breastfeeding is reported in Table 2. Out
of 233 women, 184 (78.97%) declared that they have received
information on the importance of breastfeeding. Exclusive
breastfeeding was reported by 196 women (84.12%), and
median duration of exclusive breastfeeding was 6 months (4-
7). Considering difficulties experienced during breastfeeding,
a significant proportion of women reported breast fissures
(n=77; 33.05%), engorgement (n=76; 32.62%), and poor
milk production (n=29; 12.45%). Proportion and length of
exclusive breastfeeding, as well as occurrence of specific com-
plications related to breastfeeding, were comparable among
women with versus without history of pregnancy loss.
Use of CAMs during breastfeeding and during pregnancy
among women with or without history of pregnancy loss is
described in Table 3. In both cohorts, a notable proportion
of women reported use of CAMs during pregnancy (n=70;
45.75% versus n=35; 43.75% among control women versus
womenwith history of pregnancy loss, respectively; p=0.759).
Furthermore, more than half of interviewed women declared
use of CAMs during ongoing breastfeeding: in particular, use















































Figure 1: Attitude of interviewed women towards CAMs efficacy
and safety. ∗p=0.121 and p=0.500 for efficacy and safety.
of CAMs in breastfeeding was more frequent among women
with history of pregnancy loss (n=82; 53.59% versus n=54;
67.50% among control women versus women with history of
pregnancy loss, respectively; p=0.050). Specifically, women
with history of pregnancy loss more frequently resorted
to herbal preparations (n=25; 16.34% versus n=24; 30.00%
among women without versus with history of pregnancy loss;
p=0.018), whereas phytotherapics were among the most fre-
quently taken CAMs in both cohorts (n=33; 21.57% and n=21;
26.25%, respectively). Overall, CAMs products were most
frequently reported to contain galactagogues ormultivitamin
and mineral supplements.
Advise for CAMs use was mainly provided by midwives,
gynecologists, and friends or family members, although in
both groups a relevant proportion of women resorted to
CAMs on a self-prescription basis (n=17; 11.11% and n=13;
16.25% among control women and women with history of
pregnancy loss, respectively; p=0.305).
The attitude of women towards efficacy and safety of
CAMs is described in Figure 1. Regarding efficacy, only 9.80%
4 Evidence-Based Complementary and Alternative Medicine












importance 184 (78.97) 120 (78.43) 64 (80.00) 0.866
Exclusive breastfeeding 196 (84.12) 132 (86.27) 64 (80.00) 0.258
Median duration of exclusive
breastfeeding (IQR), months 6 (4-7) 6 (4-7) 6 (4-7) 0.823
Supplements
Water 4 (1.72) 2 (1.31) 2 (2.50) 0.609
Artificial milk 34 (14.59) 20 (13.07) 14 (17.50) 0.435
Tisane 5 (2.15) 4 (2.61) 1 (1.25) 0.663
Breastfeeding-related
difficulties
Mastitis 17 (7.30) 13 (8.50) 4 (5.00) 0.431
Breast fissures 77 (33.05) 49 (32.03) 28 (35.00) 0.662
Engorgement 76 (32.62) 51 (33.33) 25 (31.25) 0.771
Inverted nipple 19 (8.15) 15 (9.80) 4 (5.00) 0.313
Poor milk production 29 (12.45) 18 (11.76) 11 (13.75) 0.679
Incompatibilities with work 10 (4.29) 7 (4.58) 3 (3.75) 1.000
Practical difficulties in
breastfeeding management 27 (11.59) 19 (12.42) 8 (10.00) 0.670
Intolerance, discomfort 14 (6.01) 11 (7.19) 3 (3.75) 0.391


















































Figure 2: Benefits and side effects reported by CAMs users during
breastfeeding. ∗p=0.762 and p=0.593 for benefits and side effects.
and 5.00% of women without and with history of pregnancy
loss believed that CAMs had higher efficacy than traditional
medications, 43.14% and 40.00% believed that CAMs were as
effective as traditional medications, and 29.41% and 32.50%
considered CAMs’ efficacy as lower. Perception on efficacy
was comparable among women without and with history
of pregnancy loss (p=0.121). 36.60% and 33.75% of women
without and with history of miscarriage or stillbirths were
convinced that CAMs were more safe than conventional
medications, whereas 35.29%and 41.25% believed that CAMs
were as safe as traditional medications, and 10.46% and
2.50% considered CAMs less safe. Perception on safety was
comparable among women without and with history of
pregnancy loss (p=0.500). Of note, 17.65% and 22.50% of
women without and with history of pregnancy loss reported
that they have no clear perception of the efficacy and safety of
CAMs.
Real benefits and side effects reported by the 82 and 54
women without and with history of pregnancy loss who used
CAMs during breastfeeding are reported in Figure 2. Most
women (65.85 and 68.52%ofwomenwithout andwith history
of pregnancy loss) reported benefits related to the use of these
products. Notably, benefits most frequently reported were
related to breast fissures (n=32), engorgement (n=34), and
poor milk production (n=12).
Regarding safety, only 7 women (5 control women and
2 women with history of pregnancy loss) declared that they
have experienced side effects during CADs use. In particular,
one woman reported mental confusion, one reported fetal
tachycardia, and one stomachache, whereas a total of four
women did not specify the experienced side effect.
4. Discussion
To the best of our knowledge, this is the first Italian study
characterizing the attitudes towards the use of CAMs among
Italian breastfeeding women with history of pregnancy loss.
Results from this post hoc analysis in the framework of
the HaBIT study [15] confirm that the use of CAMs dur-
ing breastfeeding is widespread among Italian women at
first breastfeed. Most frequently used CAMs were herbal
Evidence-Based Complementary and Alternative Medicine 5








Use of CAMs in Pregnancy
No 81 (52.94) 45 (56.25) 0.759
Yes 70 (45.75) 35 (43.75)
Missing 2 (1.31) 0
Use of CAMs in Breastfeeding
No 71 (46.41) 26 (32.50) 0.050 (∗)
Yes 82 (53.59) 54 (67.50)
Type of CAMs
Dietary supplements 26 (16.99) 17 (21.25) 0.478
Herbal preparations 25 (16.34) 24 (30.00) 0.018∗
Homeopathy 4 (2.61) 3 (3.75) 0.694
Phytotherapics 33 (21.57) 21 (26.25) 0.419
Traditional practices 7 (4.58) 1 (1.25) 0.269
Galenic preparations 1 (0.65) 0 n.c.
Domestic preparations 1 (0.65) 0 n.c.
Acupuncture 0 1 (1.25) n.c.
Others 8 (5.23) 2 (2.50) 0.501
Advise for CAMs use
Self-prescription 17 (11.11) 13 (16.25) 0.305
General practitioner 3 (1.96) 2 (2.50) 1.000
Gynaecologist 19 (12.42) 9 (11.25) 1.000
Paediatrician 17 (11.11) 8 (10.00) 1.000
Midwife 28 (18.30) 14 (17.50) 1.000
Pharmacist 5 (3.27) 3 (3.75) 1.000
Herbalist 8 (5.23) 10 (12.50) 0.068
Naturopath 4 (2.61) 2 (2.50) 1.000
Internet 11 (7.19) 4 (5.00) 0.588
Phytotherapy expert 8 (5.23) 5 (6.25) 0.769
Friends/family 17 (11.11) 13 (16.25) 0.305
Others 3 (1.96) 4 (5.00) 0.236
preparations, followed by phytotherapics and dietary sup-
plements. Specifically, results show that use of CAMs is
significantly more frequent among women with previous
history of pregnancy loss, as compared to control mothers.
This finding is of particular relevance, considering that
both interviewed groups reported comparable frequencies of
lactation-related complications, mainly represented by breast
fissures, engorgement, and poor milk production, over a
comparable median duration of exclusive breastfeeding.
Thus, more frequent use of CAMs among women with
history of pregnancy loss could be related to psychological
rather than clinical issues, probably ascribable to adverse
pregnancy-related outcomes. It is increasingly recognized
that the negative psychological and mental health conse-
quences related to pregnancy loss continue also in subsequent
pregnancies [23, 24]. Literature evidence reports higher levels
of psychological distress, pregnancy-specific anxiety, and
depression among pregnant women with history of loss [25,
26]. In this context, it is likely that interviewed women
with previous adverse pregnancy more frequently resorted to
CAMs to face consequences related to the previous pregnancy
loss. Rationale for higher use of CAMs among women with
history of loss may also rely on the higher frequency of
cesarean delivery in this group as compared to controls,
with women resorting to CAMs due to complications related
to this surgical procedure (i.e., postsurgical pain). Inde-
pendently from its possible association with CAMs use,
our finding reporting significantly higher rates of cesarean
delivery among women with history of pregnancy loss
is of particular interest. It is well described in literature
that pregnancies subsequent to losses are characterized by
increased rates of interventions such as induction of labor and
elective cesarean delivery, even when they are not associated
with an increased risk of subsequent loss [12]. A study on
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the management of pregnancy after unexplained stillbirth
revealed that elective cesarean section was often advised by
midwives, irrespectively from other clinical considerations
[27]; however, according to a web-based survey, 81% of
women who experienced stillbirth wanted early delivery and
26%wanted a cesarean delivery in the subsequent pregnancy,
independently of the medical and obstetrical advice [13, 28].
On the one hand, these mothers’ wishes for the management
of new pregnancies further highlight the anxiety and the psy-
chological burden related to previous loss. On the other hand,
these considerations further emphasize the need for an accu-
rate clinical plan for the management of pregnancy, delivery,
and postnatal care following losses, in order to provide the
most appropriate psychological and obstetrical assistance,
while minimizing the risk of unnecessary interventions.
The importance of building a solid woman-midwife rela-
tionship, founded on a specific professional expertise as well
as on a human andmedical trust, is acknowledged also by our
finding; in fact, midwives were the major advisors for CAMs
use during breastfeeding, although a nonnegligible propor-
tion of CAMs use was based on self-prescription or familiar
advice. Despite being advised about CAMs use by midwives,
a significant proportion of CAMs users reported that they
have no precise information regarding CAMs use during
breastfeeding. Nevertheless, a proportion (although minor)
of interviewed CAMs users actually reported that they have
experienced adverse events related to these products.
There is growing interest in the use of Internet-based
surveys for medical research, particularly when investigating
on sensitive topics. In fact, while accounting for several
advantages such as electronic dexterity, reduced time from
research question to answers, reduced error rates in data col-
lection, and reduced research costs [29], the use of nonfacial
survey for sensitive questions helps sharing information and
experiences without inhibition [28]. Nevertheless, given the
distance from interviewed subjects, the basic demographics
of the respondents as well as true understanding of the
questions could not be verified. Second, as for all surveys,
provided answers could be affected by recall bias. Third,
with this survey it was not possible to investigate details of
the previous loss, particularly in terms of gestational week,
and causes (i.e., unexpected or related to fetal congenital
abnormalities). Finally, the questionnaire did not provide
data on comorbidities and concomitant use of conventional
drugs; thus, we could not evaluate the association between
these factors and CAMs use.
5. Conclusions
The new pregnancy and perinatal period following miscar-
riage or stillbirth are usually accompanied by anxiety and
psychological difficulties, not only for the couple but also for
the caregivers. Overcoming the social taboo of pregnancy
loss and training healthcare professionals for a psycholog-
ically and clinically adequate management of the perinatal
period and related complications, with a particular focus on
breastfeeding, are essential for an effective and safe care of
both mothers and newborns. Although our results reported a
common use and advice on CAMs use during breastfeeding,
it is important for both mothers and healthcare professionals
to acknowledge that limited evidence supports their safety
and efficacy during such critical period.
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